These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28063303)

  • 1. Peptides and peptidomimetics as regulators of protein-protein interactions.
    Cunningham AD; Qvit N; Mochly-Rosen D
    Curr Opin Struct Biol; 2017 Jun; 44():59-66. PubMed ID: 28063303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides and peptidomimetics as inhibitors of protein-protein interactions involving β-sheet secondary structures.
    Laxio Arenas J; Kaffy J; Ongeri S
    Curr Opin Chem Biol; 2019 Oct; 52():157-167. PubMed ID: 31590141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of RNA-targeting macrocyclic peptides.
    Walker MJ; Varani G
    Methods Enzymol; 2019; 623():339-372. PubMed ID: 31239053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidomimetic toolbox for drug discovery.
    Lenci E; Trabocchi A
    Chem Soc Rev; 2020 Jun; 49(11):3262-3277. PubMed ID: 32255135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides, Peptidomimetics, and Polypeptides from Marine Sources: A Wealth of Natural Sources for Pharmaceutical Applications.
    Sable R; Parajuli P; Jois S
    Mar Drugs; 2017 Apr; 15(4):. PubMed ID: 28441741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in the design of insulin and relaxin/insulin-like peptide mimetics.
    Hossain MA; Bathgate RAD
    Bioorg Med Chem; 2018 Jun; 26(10):2827-2841. PubMed ID: 28988628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of α-helix-mimicking sulfono-γ-AApeptides as p53-MDM2 inhibitors.
    Shi Y; Sang P; Cai J
    Future Med Chem; 2021 Jun; 13(12):1021-1023. PubMed ID: 33906432
    [No Abstract]   [Full Text] [Related]  

  • 9. Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease.
    Goyal D; Shuaib S; Mann S; Goyal B
    ACS Comb Sci; 2017 Feb; 19(2):55-80. PubMed ID: 28045249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclopropane-Based Peptidomimetics Mimicking Wide-Ranging Secondary Structures of Peptides: Conformational Analysis and Their Use in Rational Ligand Optimization.
    Mizuno A; Kameda T; Kuwahara T; Endoh H; Ito Y; Yamada S; Hasegawa K; Yamano A; Watanabe M; Arisawa M; Shuto S
    Chemistry; 2017 Mar; 23(13):3159-3168. PubMed ID: 28000361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical construction and structural permutation of potent cytotoxin polytheonamide B: discovery of artificial peptides with distinct functions.
    Itoh H; Inoue M
    Acc Chem Res; 2013 Jul; 46(7):1567-78. PubMed ID: 23488446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane.
    Mizuno A; Matsui K; Shuto S
    Chemistry; 2017 Oct; 23(58):14394-14409. PubMed ID: 28632330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational Preferences and Antiproliferative Activity of Peptidomimetics Containing Methyl 1'-Aminoferrocene-1-carboxylate and Turn-Forming Homo- and Heterochiral Pro-Ala Motifs.
    Kovačević M; Čakić Semenčić M; Radošević K; Molčanov K; Roca S; Šimunović L; Kodrin I; Barišić L
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides-staple method development and its application in cancer therapy.
    Zhang QZ; Tian Y; Lao YZ; Li ZG
    Curr Med Chem; 2014; 21(21):2438-52. PubMed ID: 24524768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfonyl γ-AApeptide tools for modulating biology.
    Fontaine J; Cai J
    Methods Enzymol; 2024; 698():247-262. PubMed ID: 38886034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments with metalloprotease inhibitor class of drug candidates for botulinum neurotoxins.
    Kumar G; Swaminathan S
    Curr Top Med Chem; 2015; 15(7):685-95. PubMed ID: 25751268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided design of amino acid-based therapeutics: a review.
    Farhadi T; Hashemian SM
    Drug Des Devel Ther; 2018; 12():1239-1254. PubMed ID: 29795978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of covalent Siah inhibitors.
    Stebbins JL; Santelli E; Feng Y; De SK; Purves A; Motamedchaboki K; Wu B; Ronai ZA; Liddington RC; Pellecchia M
    Chem Biol; 2013 Aug; 20(8):973-82. PubMed ID: 23891150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide science: A "rule model" for new generations of peptidomimetics.
    Reese HR; Shanahan CC; Proulx C; Menegatti S
    Acta Biomater; 2020 Jan; 102():35-74. PubMed ID: 31698048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic Peptides for Protein-Protein Interaction Targets: Applications to Human Disease.
    Rubin S; Qvit N
    Crit Rev Eukaryot Gene Expr; 2016; 26(3):199-221. PubMed ID: 27650985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.